Figures & data
Figure 2. (a) Phage ELISA results with several single clones towards 3F11 with 50 ng/mL FB1 (red column), without FB1 (black column) or BSA (slash column). (b) Noncompetitive idiometric nanobodies phage ELISA for FB1 set up with different phage Ab2α. Data are reported as an average ± standard error.
![Figure 2. (a) Phage ELISA results with several single clones towards 3F11 with 50 ng/mL FB1 (red column), without FB1 (black column) or BSA (slash column). (b) Noncompetitive idiometric nanobodies phage ELISA for FB1 set up with different phage Ab2α. Data are reported as an average ± standard error.](/cms/asset/d2a645a4-8e5d-484f-8432-adfea7c03cb7/cfai_a_1604637_f0002_oc.jpg)
Figure 3. (a) Cross-reactivity of the noncompetitive idiometric nanobodies phage ELISA with other mycotoxins. (b) Cross-reactivity of the noncompetitive idiometric nanobodies phage ELISA with primary antibodies and mycotoxins.
![Figure 3. (a) Cross-reactivity of the noncompetitive idiometric nanobodies phage ELISA with other mycotoxins. (b) Cross-reactivity of the noncompetitive idiometric nanobodies phage ELISA with primary antibodies and mycotoxins.](/cms/asset/40c83e91-90ad-4966-8287-f3998dcaadd6/cfai_a_1604637_f0003_oc.jpg)
Figure 4. Calibration curves of FB1 in PBS and in sample extracts of different dilutions with or without solid phase extraction.
![Figure 4. Calibration curves of FB1 in PBS and in sample extracts of different dilutions with or without solid phase extraction.](/cms/asset/f6dd5aa1-35e0-4e93-a885-5f0bb49a8291/cfai_a_1604637_f0004_oc.jpg)